One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.
Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback